Avricore Health Makes the Grade on 2023 TSX Venture 50
VANCOUVER, British Columbia, Feb. 21, 2023 (GLOBE NEWSWIRE) — AVRICORE HEALTH INC. (TSXV: AVCR) (the “Company” or “AVCR”) has been honoured by being named as one of the 2023 Venture 50, the TSX Venture Exchange’s list of top performing companies.
Related news for (AVCRF)
- AVRICORE HEALTH CORPORATE UPDATE – COMPANY ACHIEVES PROFITABILITY
- Avricore Health Corporate Update and Audited Results for 2023
- HealthTab™ Signs Agreement for More Rexall® Pharmacy Locations
- Avricore Health Corporate Update – Company Demonstrates Strong Growth
- HealthTab™ Supports Patient Testing in the First Rexall® Pharmacy Walk-In Clinic